highly significantP < .001
Further, highly significant decrease was noted with administration of high-dose artesunate ( P < .001) in GSH, G-Px, and G-Rx after 45 days of treatment.
Further, highly significant decrease was noted with administration of high-dose artesunate ( P < .001) in GSH, G-Px, and G-Rx after 45 days of treatment.